Head and neck cancer organoids as a step towards personalized treatments

byHubrecht InstituteHNC organoids from the biobank. Credit: Organoid group, copyright Hubrecht Institute.Head and neck cancer (HNC) is an overarching term used for several types of cancer, inclu

Updated on: January 07,2024

Head and neck cancer organoids as a step towards personalized treatments

byHubrecht InstituteHNC organoids from the biobank. Credit: Organoid group, copyright Hubrecht Institute.Head and neck cancer (HNC) is an overarching term used for several types of cancer, inclu

Updated on:January 07,2024

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

Updated on: March 27,2024

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

Updated on:March 27,2024

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Updated on: August 03,2024

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Updated on:August 03,2024

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on: January 30,2024

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on:January 30,2024

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on: March 14,2024

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on:March 14,2024

Study identifies risk factors for early onset colorectal cancer in males

by Regenstrief InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but

Updated on: February 18,2024

Study identifies risk factors for early onset colorectal cancer in males

by Regenstrief InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but

Updated on:February 18,2024

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on: March 13,2024

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on:March 13,2024

Early-life alcohol intake may increase the odds of high-grade prostate cancer

by American Association for Cancer ResearchMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Compared with non-drink

Updated on: April 20,2024

Early-life alcohol intake may increase the odds of high-grade prostate cancer

by American Association for Cancer ResearchMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Compared with non-drink

Updated on:April 20,2024

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni

Updated on: March 09,2024

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni

Updated on:March 09,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on: March 20,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on:March 20,2024

Geographical, racial/ethnic differences seen for triple-negative breast cancer

by Lori SolomonThere are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online Mar

Updated on: January 03,2024

Geographical, racial/ethnic differences seen for triple-negative breast cancer

by Lori SolomonThere are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online Mar

Updated on:January 03,2024

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on: April 01,2024

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on:April 01,2024